FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On September 25, 2003
Table of Contents
Docket # Title
1979P-0236 Laser light show
1995D-0349 Immediate Release Solid Oral Dosage Forms;Scale-Up & Postapr
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1998V-0817 Variance for emission delay for BioFlex Professional Laser
2003D-0236 Draft "Guidance for Industry: Revised Recommendations for Donor and Product Management Based on Screening Tests for Syphilis;" Availability
2003D-0382 Draft Guidance: Sterile Drug Products Produced by Aseptic Processing
2003E-0448 Patent Extension for FACTIVE, gemifloxacin mesylate, #5,776,944
2003N-0294 Risk Management Plans for Opiate Analgesic Drug
2003N-0361 Anti-Counterfeit Drug Initiative
2003P-0121 Enforcing the patent certification requirements in FD&C Act
2003P-0291 Enforce the law and prevent unlaw sale of contact lens
2003P-0436 (ANDA) containing 300 mg Acetaminophen/ 5 mg Hydrocodone, 300 mg Acetaminophen/ 7.5 mg Hydrocodone, 300 mg Acetaminophen/ 10 mg Hydrocodone
2003P-0437 refrain from covering the General and Plastic Surgery Devices panel of the Medical Devices Advsory committee on 10/14/03
2003P-0438 change the regulatory status of prenatal listening devices commonly called "Doppler Fetoscopes" under 21 CFR 5.10
2003P-0450 De Novo Petition for West Nile Virus IgM Capture ELISA
2003V-0440 Laser Light Show
1979P-0236 Laser light show
VRA 9 HFZ-300 to Laser Magic Productions Vol #: 1
1995D-0349 Immediate Release Solid Oral Dosage Forms;Scale-Up & Postapr
RPT 12
Attachment 1, 2
Netzsch Incorporated Vol #: 5
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
EXT 1 number not used Vol #: 84
LET 11044 Quorum Global Limited Vol #: 84
1998V-0817 Variance for emission delay for BioFlex Professional Laser
EXP 1
Enclosed
Meditech International Inc. Vol #: 1
2003D-0236 Draft "Guidance for Industry: Revised Recommendations for Donor and Product Management Based on Screening Tests for Syphilis;" Availability
C 5 American Red Cross Vol #: 1
2003D-0382 Draft Guidance: Sterile Drug Products Produced by Aseptic Processing
C 1
Enclosed
The Williamsburg Group Vol #: 1
2003E-0448 Patent Extension for FACTIVE, gemifloxacin mesylate, #5,776,944
APP 1 LG Life Sciences, Ltd Vol #: 1
LET 1 U S Patent and Trademark Office Vol #: 1
2003N-0294 Risk Management Plans for Opiate Analgesic Drug
EMC 3 consumer Vol #: 1
EMC 4 Number not used Vol #: 1
EMC 5 Jeannine M Martin Vol #: 1
2003N-0361 Anti-Counterfeit Drug Initiative
C 2 Pharmaceutical Systems, Inc. Vol #: 1
2003P-0121 Enforcing the patent certification requirements in FD&C Act
LET 1 HFD-005 to Keller and Heckman, LLP Vol #: 1
2003P-0291 Enforce the law and prevent unlaw sale of contact lens
C 46 Jane Ireland, O.D. Vol #: 1
C 47 N. William Ritz, O.D. Vol #: 1
C 48 Dr. Michael Georgescu Vol #: 1
C 49 Dr. Kruger Vol #: 1
C 50 Leo J. Santucci, O.D. Vol #: 1
2003P-0436 (ANDA) containing 300 mg Acetaminophen/ 5 mg Hydrocodone, 300 mg Acetaminophen/ 7.5 mg Hydrocodone, 300 mg Acetaminophen/ 10 mg Hydrocodone
ACK 1 Anabolic Laboratories, Inc. Vol #: 1
2003P-0437 refrain from covering the General and Plastic Surgery Devices panel of the Medical Devices Advsory committee on 10/14/03
ACK 2 number not used Vol #: 1
2003P-0438 change the regulatory status of prenatal listening devices commonly called "Doppler Fetoscopes" under 21 CFR 5.10
ACK 2 number not used Vol #: 1
2003P-0450 De Novo Petition for West Nile Virus IgM Capture ELISA
CP 1 PANBIO Limited Vol #: 1
2003V-0440 Laser Light Show
ACK 1 HFA-305 to Area 54 DJ Co. Vol #: 1
ACK 2 Number not used Vol #: 1

Page Posted September 26, 2003 dp
Page updated October 6, 2003 jb

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management